Business
A Global Clinical Trial of a Drug That Has Been Approved in China for Treating ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'A global clinical trial of a drug that has been approved in China for treating Alzheimer’s disease was terminated due to lack of funding and Covid-19 disruptions ...'
A global clinical trial of a drug that has been approved in China for treating Alzheimer’s disease was terminated due to lack of funding and Covid-19 disruptions https://t.co/TOrdYFEK18— Bloomberg (@business) May 13, 2022
(The above story first appeared on LatestLY on May 13, 2022 11:00 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
